Home > Healthcare > Biotechnology > Bioservices > Bio-Decontamination Market

Bio-Decontamination Market Trends

  • Report ID: GMI8491
  • Published Date: Mar 2024
  • Report Format: PDF

Bio-Decontamination Market Trends

The rapid expansion of the pharmaceutical and biotechnology industry has spurred a parallel growth trajectory in the demand for stringent bio-decontamination measures. As pharmaceutical and biotechnology companies strive for innovation and quality in their research, development, and manufacturing processes, the need to maintain clean and contamination-free environments becomes paramount.
 

  • Pharmaceutical and biotechnology products are often highly sensitive and susceptible to contamination. Even trace amounts of contaminants can compromise product quality, efficacy, and safety. This is particularly critical in the production of sterile drugs, biologics, vaccines, and medical devices, where the risk of microbial contamination must be minimized to prevent adverse effects on patients.
     
  • Further, these sectors are heavily regulated by stringent quality and safety standards imposed by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Compliance with these regulations requires meticulous attention to cleanliness, sterility, and contamination control throughout the manufacturing process.
     
  • Moreover, the growth of the pharmaceutical and biotechnology industry has created a pressing need for effective bio-decontamination solutions to safeguard product quality, regulatory compliance, and patient safety.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bio-decontamination market was worth USD 229.5 million in revenue in 2023 and is estimated to surpass USD 475.5 million by 2032 driven by the increasing prevalence of hospital-acquired infections (HAIs) globally.

The equipment segment generated USD 145.6 million in 2023 and is projected to record substantial growth through 2032 owing to rising demand as they are engineered with built-in safety features to prevent exposure to hazardous chemicals or radiation during operation.

North America bio-decontamination industry size was USD 93 million in 2023 and is set to expand at a notable CAGR from 2024-2032 attributed to the continuous growth of the pharmaceutical and biotechnology sectors, and the increasing trend of outsourcing bio-decontamination services to third-party providers in the region.

Leading bio-decontamination industry players are AM Instruments Srl, Ecolab Inc., Fedegari Autoclavi SpA, Howorth Air Technology Limited, JCE Biotechnology, Noxilizer, Inc., STERIS plc, Tecomak., TOMI Environmental Solutions, Inc., and Vaisala.

Bio-Decontamination Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 278
  • Countries covered: 22
  • Pages: 195
 Download Free Sample